Psychemedics Cash Flow from Operating Activities 2010-2024 | PMD

Psychemedics cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
Psychemedics Annual Cash Flow Ops
(Millions of US $)
2023 $-1
2022 $5
2021 $0
2020 $-4
2019 $4
2018 $8
2017 $9
2016 $9
2015 $5
2014 $4
2013 $6
2012 $3
2011 $4
2010 $3
2009 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.015B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.023B 10.30
Quest Diagnostics (DGX) United States $16.035B 16.57
DaVita (DVA) United States $12.262B 15.23
Encompass Health (EHC) United States $8.604B 22.02
Chemed (CHE) United States $8.562B 26.54
Elanco Animal Health (ELAN) United States $8.495B 22.04
Option Care Health (OPCH) United States $5.176B 19.59
RadNet (RDNT) United States $4.244B 88.39
Amedisys (AMED) United States $3.086B 21.86
LifeStance Health (LFST) United States $2.825B 0.00
Astrana Health (ASTH) United States $2.291B 30.99
Addus HomeCare (ADUS) United States $1.812B 25.92
U.S Physical Therapy (USPH) United States $1.608B 43.03
Pennant (PNTG) United States $0.692B 36.54
Aveanna Healthcare Holdings (AVAH) United States $0.512B 0.00
Atai Life Sciences (ATAI) Germany $0.286B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00